Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
Positive Signs As Multiple Insiders Buy DocGo Stock
Northland Securities Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $8
Northland Securities analyst Michael Latimore maintains $DocGo(DCGO.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 51.3%
Northland Securities Sticks to Its Buy Rating for DocGo (DCGO)
DocGo Announces Participation at Four Upcoming Investor Conferences
Cantor Fitzgerald Reiterates Overweight on DocGo, Maintains $5 Price Target
We Think That There Are Issues Underlying DocGo's (NASDAQ:DCGO) Earnings
DocGo: A Strong Buy on Robust Financial Performance and Growth Prospects
DocGo Inc.'s (NASDAQ:DCGO) Price Is Right But Growth Is Lacking After Shares Rocket 28%
DocGo Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Revenue Results.
Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday
Northland Securities Remains a Buy on DocGo (DCGO)
Buy Rating Affirmed for DocGo on Strong Quarterly Performance and Positive Growth Trajectory
DocGo Price Target Maintained With a $7.00/Share by Needham
Analysts Offer Insights on Healthcare Companies: Curaleaf Holdings (OtherCURLF) and DocGo (DCGO)
DocGo Analyst Ratings
DocGo GAAP EPS of $0.06 In-line, Revenue of $164.95M Misses by $0.82M
Express News | DocGo Inc -Qtrly EPS $0.06
Express News | DocGo Inc -Raises Cash Flow From Operations Guidance to $80-$90 Mln for 2024
Express News | DocGo Inc -Reiterates 2024 Revenue Guidance of $600-$650 Mln and Adjusted Ebitda Guidance of $65-$75 Mln